These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15843238)

  • 1. A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses.
    Apperloo JJ; Vader HL
    Clin Chem Lab Med; 2005; 43(3):314-8. PubMed ID: 15843238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maltose, a promising osmotic agent in peritoneal dialysis solution.
    Shu ZJ; Peng YM; Sun L; Xiao L; Liu YH; Li J; Ling GH; Tang WB; Halmurat U; Liu FY
    Med Hypotheses; 2010 Dec; 75(6):645-7. PubMed ID: 20801582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The danger of using inappropriate point-of-care glucose meters in patients on icodextrin dialysis.
    Perera NJ; Stewart PM; Williams PF; Chua EL; Yue DK; Twigg SM
    Diabet Med; 2011 Oct; 28(10):1272-6. PubMed ID: 21679233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icodextrin:a major problem for glucose dehydrogenase-based glucose point of care testing systems.
    Floré K; Delanghe J
    Acta Clin Belg; 2006; 61(6):351-4. PubMed ID: 17323845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overestimation by a hand-held glucometer of blood glucose level due to icodextrin.
    King DA; Ericson RP; Todd NW
    Isr Med Assoc J; 2010 May; 12(5):314-5. PubMed ID: 20929091
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism.
    de Boer AW; Schröder CH; van Vliet R; Willems JL; Monnens LA
    Pediatr Nephrol; 2000 Nov; 15(1-2):21-4. PubMed ID: 11095005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer.
    Wens R; Taminne M; Devriendt J; Collart F; Broeders N; Mestrez F; Germanos H; Dratwa M
    Perit Dial Int; 1998; 18(6):603-9. PubMed ID: 9932659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.
    MacGinley R; Cooney K; Alexander G; Cohen S; Goldsmith DJ
    Am J Kidney Dis; 2002 Nov; 40(5):1030-5. PubMed ID: 12407649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inaccurate self-monitoring of blood glucose readings in patients on chronic ambulatory peritoneal dialysis with icodextrin.
    Pavlicek V; Garzoni D; Urech P; Brändle M
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):124-6. PubMed ID: 16636978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased in vitro formation of AGEs with extraneal solution compared to dextrose-containing peritoneal dialysis solutions.
    Barre DE; Chen C; Cooker L; Moberly JB
    Adv Perit Dial; 1999; 15():12-6. PubMed ID: 10682064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of interference of icodextrin on creatinine measurements.
    Burke RA; Hughes G; Moberly JB
    Adv Perit Dial; 1999; 15():234-7. PubMed ID: 10682109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Icodextrin in peritoneal dialysis therapy].
    Grzegorzewska AE; Antczak-Jedrzejczak D
    Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypoglycaemic coma due to falsely elevated glucose values in a patient with diabetes mellitus and peritoneal dialysis].
    Nienhuis WA; Bruijns RH; Vastenburg G; Wouters RS
    Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1574-6. PubMed ID: 16886696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems.
    Schleis TG
    Pharmacotherapy; 2007 Sep; 27(9):1313-21. PubMed ID: 17723085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with icodextrin. Multicenter study].
    Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
    Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoidable iatrogenic hypoglycemia in patients on peritoneal dialysis: the risks of nonspecific glucose monitoring devices and drug-device interaction.
    Firanek CA; Jacob DT; Sloand JA
    J Patient Saf; 2014 Dec; 10(4):218-21. PubMed ID: 23860196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.